Industry News and Headlines

How CathWorks Leaned on Its Partner Medtronic to Succeed

CathWorks, an AI‑driven startup that creates non‑invasive FFR assessments from routine angiograms, survived the pandemic by leaning on Medtronic’s early minority investment and strategic guidance. After automating its 3‑D coronary modeling to cut analysis time from 22 minutes to two, the company secured FDA, EU and Japan clearances and completed five global validation studies. Medtronic announced a deal to acquire CathWorks for up to $585 million, aiming to embed the technology in its cath‑lab portfolio. The acquisition comes as CathWorks prepares to present a 1,900‑patient randomized trial at the ACC meeting.